Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus intrathecal dexmedetomidine for prevention of shivering after spinal anesthesia
IRCT20171014036771N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine, bupivacaine and sodium chloride in postanesthetic shivering (PAS) (3 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: shivering, core body temperature and 3 more. Started Jan 2019; status: completed.
02
Drugs
dexmedetomidinebupivacainesodium chloride
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20171014036771N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171014036771N1.